Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009217
Chunk: 90

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 90
---
146.3 below;

| (C) | As regards capital |

The holders of D Deferred Shares shall
on a return of capital in a liquidation, but not otherwise, be entitled to receive the nominal amount paid up or credited as paid up on
such share but only after the holder of each Ordinary Share shall have received (in cash or specie) the amount paid up or credited as
paid up on such Ordinary Share together with an additional payment of £100 per Ordinary Share and the holders of D Deferred Shares
shall be not entitled to any further or other right of participation in the assets or profits of the Company whatsoever;

| 71 |

| (D) | As regards variation of rights |

| (1) | The rights attached to the D Deferred Shares shall not be deemed to be varied or                                                 
 abrogated by the creation or issue of any new shares ranking in priority to or pail passu with or subsequent to such shares; and |

| (2) | Neither. |

| (a) | the passing by the Company of any resolution for the cancellation of the D Deferred                                                     
 Shares (whether for no consideration or otherwise) by means of a reduction of capital (whether or not requiring the confirmation of the 
 Court) nor the obtaining by the Company nor the making by the Court of any order confirming any such reduction of capital nor any such  
 order becoming effective; nor                                                                                                           |

| (b) | the purchase by the Company in accordance with the Act of any of its own shares 
 or securities (or the passing of a resolution to permit any such purchase); nor |

| (c) | any other reduction of share capital including without limitation the reduction                                                            
 of any share premium account of the Company, shall constitute a variation, modification or abrogation of the rights attaching to the D     
 Deferred Shares and the D Deferred Shares may at any time be cancelled (whether for no consideration or otherwise) by means of a reduction 
 of capital or repurchased in either case in accordance with the Act without the sanction or other consent of the holders of the D Deferred 
 Shares.                                                                                                                                    |

| (E) | Share        
 certificates |

Notwithstanding any other provision
of the Articles and unless specifically required by the provisions of the Act, the Company shall not be required to issue any certificate
in respect of the D Deferred Shares.

| 146.2 | At any time after the adoption of these Articles: |

| (A) | The Company shall have irrevocable authority to appoint any